Drug Testing and Analysis

Drug Testing and Analysis

DRUG TEST ANAL
影响因子:2.7
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:John Wiley and Sons Ltd
发刊时间:2009
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:1942-7603

期刊介绍

As the incidence of drugs escalates in 21st century living, their detection and analysis have become increasingly important. Sport, the workplace, crime investigation, homeland security, the pharmaceutical industry and the environment are just some of the high profile arenas in which analytical testing has provided an important investigative tool for uncovering the presence of extraneous substances.In addition to the usual publishing fare of primary research articles, case reports and letters, Drug Testing and Analysis offers a unique combination of; ‘How to’ material such as ‘Tutorials’ and ‘Reviews’, Speculative pieces (‘Commentaries’ and ‘Perspectives', providing a broader scientific and social context to the aspects of analytical testing), ‘Annual banned substance reviews’ (delivering a critical evaluation of the methods used in the characterization of established and newly outlawed compounds).Rather than focus on the application of a single technique, Drug Testing and Analysis employs a unique multidisciplinary approach to the field of controversial compound determination. Papers discussing chromatography, mass spectrometry, immunological approaches, 1D/2D gel electrophoresis, to name just a few select methods, are welcomed where their application is related to any of the six key topics listed below.
随着毒品在21世纪生活中发病率的上升,其检测和分析变得越来越重要。体育、工作场所、犯罪调查、国土安全、制药业和环境只是其中一些引人注目的领域,在这些领域中,分析测试为发现外来物质的存在提供了重要的调查工具。除了通常的主要研究文章、案例报告和信件的出版费用外,药物测试和分析还提供了以下方面的独特组合:“如何"材料,如”教程“和”评论“,推测性文章(“评论”和“观点”,为分析测试的各个方面提供了更广泛的科学和社会背景),“年度禁用物质审查”(对已确立和新宣布为非法的化合物的表征所用的方法进行严格评价)。药物测试和分析采用了独特的多学科方法来确定有争议的化合物。讨论色谱法、质谱法、免疫学方法、一维/二维凝胶电泳等方法的论文,只要其应用与下列六个关键主题中的任何一个相关,都是受欢迎的。
年发文量 176
国人发稿量 11.46
国人发文占比 0.07%
自引率 -
平均录取率0
平均审稿周期 平均3.0个月
版面费 US$4700
偏重研究方向 BIOCHEMICAL RESEARCH METHODS-CHEMISTRY, ANALYTICAL
期刊官网 http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1942-7611
投稿链接 http://mc.manuscriptcentral.com/dta

期刊高被引文献

Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2517
Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2566
Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2491
Sulfate metabolites improve retrospectivity after oral testosterone administration.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2529
Microfluidic electrochemical immunosensor for the trace analysis of cocaine in water and body fluids.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2515
Monitoring of direct alcohol markers in alcohol use disorder patients during withdrawal treatment and successive rehabilitation.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2567
Analytical quantification, intoxication case series, and pharmacological mechanism of action for N-ethylnorpentylone (N-ethylpentylone or ephylone).
来源期刊:Drug testing and analysisDOI:10.1002/dta.2502
Quantification of cocaine and cocaine metabolites in dried blood spots from a controlled administration study using liquid chromatography-tandem mass spectrometry.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2537
5F-MDMB-PICA Metabolite Identification and Cannabinoid Receptor Activity.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2688
Stability of mephedrone and five of its phase I metabolites in human whole blood.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2525
Development of a mono-specific anti-VEGF bivalent nanobody with extended plasma half-life for treatment of pathologic neovascularization.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2693
A fatal chemsex case involving γ-butyrolactone and 4-methylethcathinone.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2677
Decarbonylation: A metabolic pathway of cannabidiol in humans.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2572
Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2652
Oxytocin analysis from human serum, urine, and saliva by orbitrap liquid chromatography-mass spectrometry.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2475
Retrospective analysis for valproate screening targets with liquid chromatography-high resolution mass spectrometry with positive electrospray ionization: An omics-based approach.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2543
A systematic investigation of forensic hair decontamination procedures and their limitations.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2681
LC-MS/MS Screening Method Using Information-Dependent Acquisition of Enhanced Product Ion Mass Spectra for Synthetic Cannabinoids Including Metabolites in Urine.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2664
Hair analysis to discriminate voluntary doping vs inadvertent ingestion of the aromatase inhibitor letrozole.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2555
Gas chromatography-mass spectrometry analysis of non-hydrolyzed sulfated steroids by degradation product formation.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2606
Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2494
Elimination profile of triamcinolone hexacetonide and its metabolites in human urine and plasma after a single intra-articular administration.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2614
Budesonide use and misuse in sports: elimination profiles of budesonide and metabolites after intranasal, high-dose inhaled and oral administrations.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2678
Meldonium long-term excretion period and pharmacokinetics in blood and urine of healthy athlete volunteers.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2521
Evidence of seasonal variation of ethyl glucuronide in hair: Modeling a seven-year data series.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2470
1 H-15 N HMBC NMR as a tool for rapid identification of isomeric azaindoles: The case of 5F-MDMB-P7AICA.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2573
Detection of the myostatin-neutralizing antibody Domagrozumab in serum by means of Western blotting and LC-HRMS.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2729
Determination of DP-VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC-MS/MS: A clinical pharmacokinetics and excretion study.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2579
A comprehensive approach to detecting multitudinous bioactive peptides in equine plasma and urine using HILIC coupled to high resolution mass spectrometry.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2671
Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2680
7-keto-DHEA metabolism in humans. Pitfalls in interpreting the analytical results in the antidoping field.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2734
Development of an ultra-high performance liquid chromatography-tandem mass spectrometry method for the determination of anabolic steroids currently available on the black market in the Czech Republic and Slovakia.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2541
The use of hair as a long-term indicator of low-dose β2 agonist treatments in cattle: Implications for growth-promoting purposes monitoring.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2551
Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?
来源期刊:Drug testing and analysisDOI:10.1002/dta.2682
In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2611
Ionized magnesium and calcium concentration and their ratio in equine plasma samples as determined by a regulatory laboratory compared to a clinical reference laboratory.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2509
Isotopically labeled boldenone as a better marker of derivatization efficiency for improved quality control in anti-doping analysis.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2556
Creatinine excretion in consecutive urine samples after controlled ingestion of water.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2514
The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: an incentive for controlling agencies to prepare for future encounters of the kind.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2717
Identification of phenobarbital and other barbiturates in forensic drug screening using positive electrospray ionization liquid chromatography-high resolution mass spectrometry.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2603
Isotopomics by isotope ratio monitoring by 13 C Nuclear Magnetic Resonance Spectrometry on cutting agents in heroin: a new approach for illicit drugs trafficking route elucidation.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2745
Optimization and validation of simultaneous analyses of ecgonine, cocaine, and seven metabolites in human urine by gas chromatography-mass spectrometry using a one-step solid-phase extraction.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2547
Analysis of tretoquinol and its metabolites in human urine by liquid chromatography-tandem mass spectrometry.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2714
Detection of ESAs in equine urine and blood by SAR-PAGE.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2569
Urinary concentrations of AICAR and mannitol in athlete population.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2557
Detection and characterization of the new synthetic cannabinoid APP-BINACA in forensic casework.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2698
Evaluation of an on-site test device for the heroin metabolite 6-acetylmorphine in urine.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2559
An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2554
Metabolism of vesatolimod in rat, dog, and human liver microsomes: Metabolic stability assessment, metabolite identification, and interspecies comparison.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2483
Administration study of recombinant human relaxin-2 in horse for doping control purpose.
来源期刊:Drug testing and analysisDOI:10.1002/dta.2732

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
94.32%37.89%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
BIOCHEMICAL RESEARCH METHODS
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
3区
CHEMISTRY, ANALYTICAL 分析化学
3区
PHARMACOLOGY & PHARMACY 药学
3区
2023年12月升级版
医学3区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
2区
CHEMISTRY, ANALYTICAL 分析化学
2区
PHARMACOLOGY & PHARMACY 药学
3区
2022年12月旧的升级版
医学3区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
2区
CHEMISTRY, ANALYTICAL 分析化学
2区
PHARMACOLOGY & PHARMACY 药学
3区